MSF representatives are attending the 142nd session of the WHO executive board meetings and will be attending and speaking on a number of topics.
The following briefings have been distributed to delegates:
The following statements have been delivered:
Agenda Item 3.6: Addressing global shortage and access medicines and vaccines
Agenda Item 3.7: Global strategy and plan action public health innovation and intellectual property
Agenda Item 3.9: Preparation high-level meeting of the General Assembly on ending tuberculosis
Agenda item 4.1: Global snakebite burden
Agenda item 6.2: Global vaccine action plan